Journey Medical Corporati... (DERM)
Journey Medical Statistics
Share Statistics
Journey Medical has 23.11M shares outstanding. The number of shares has increased by 4.38% in one year.
| Shares Outstanding | 23.11M |
| Shares Change (YoY) | 4.38% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 18.41% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,260 |
| FTD / Avg. Volume | 4.23% |
Short Selling Information
The latest short interest is 252.11K, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 252.11K |
| Short % of Shares Out | 1.09% |
| Short % of Float | 3.76% |
| Short Ratio (days to cover) | 2.09 |
Valuation Ratios
The PE ratio is -5.44 and the forward PE ratio is 12.61. Journey Medical's PEG ratio is -0.02.
| PE Ratio | -5.44 |
| Forward PE | 12.61 |
| PS Ratio | 1.42 |
| Forward PS | 0.8 |
| PB Ratio | 3.98 |
| P/FCF Ratio | -8.75 |
| PEG Ratio | -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Journey Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.25.
| Current Ratio | 1.37 |
| Quick Ratio | 0.96 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | -2.96 |
| Debt / FCF | -2.75 |
| Interest Coverage | -5.07 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1,369,121.95 |
| Profits Per Employee | $-357,853.66 |
| Employee Count | 41 |
| Asset Turnover | 0.7 |
| Inventory Turnover | 1.45 |
Taxes
| Income Tax | 61K |
| Effective Tax Rate | -0.42% |
Stock Price Statistics
The stock price has increased by 90.36% in the last 52 weeks. The beta is 0.91, so Journey Medical's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | 90.36% |
| 50-Day Moving Average | 6.05 |
| 200-Day Moving Average | 5.34 |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 77,124 |
Income Statement
In the last 12 months, Journey Medical had revenue of 56.13M and earned -14.67M in profits. Earnings per share was -0.72.
| Revenue | 56.13M |
| Gross Profit | 35.26M |
| Operating Income | -13.68M |
| Net Income | -14.67M |
| EBITDA | -8.49M |
| EBIT | -11.91M |
| Earnings Per Share (EPS) | -0.72 |
Balance Sheet
The company has 20.3M in cash and 25.08M in debt, giving a net cash position of -4.78M.
| Cash & Cash Equivalents | 20.3M |
| Total Debt | 25.08M |
| Net Cash | -4.78M |
| Retained Earnings | -87.03M |
| Total Assets | 80.24M |
| Working Capital | 13M |
Cash Flow
In the last 12 months, operating cash flow was -9.13M and capital expenditures 0, giving a free cash flow of -9.13M.
| Operating Cash Flow | -9.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.13M |
| FCF Per Share | -0.45 |
Margins
Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.
| Gross Margin | 62.81% |
| Operating Margin | -24.36% |
| Pretax Margin | -26.03% |
| Profit Margin | -26.14% |
| EBITDA Margin | -15.12% |
| EBIT Margin | -24.36% |
| FCF Margin | -16.26% |
Dividends & Yields
DERM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for DERM is $10, which is 44.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 44.7% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | 0.61 |
| Piotroski F-Score | 3 |